GeneBioTech Co. Ltd (086060) — Long-term Investment Intensity
GeneBioTech Co. Ltd (086060) has a Long-term Investment Intensity of 4.6% as of December 2019. Long-term investments of ₩3.11 Billion represent 4.6% of total assets of ₩67.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 086060 net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GeneBioTech Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how GeneBioTech Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 4.6%, reflecting long-term investments of ₩3.11 Billion against total assets of ₩67.93 Billion KRW. Also explore 086060 total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for GeneBioTech Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for GeneBioTech Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of GeneBioTech Co. Ltd.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.6% | ₩3.11 Billion | ₩67.93 Billion | ▼ -1.8 pp |
| 2018 | 6.4% | ₩4.64 Billion | ₩72.63 Billion | ▼ -7.6 pp |
| 2017 | 14.0% | ₩8.31 Billion | ₩59.54 Billion | ▼ -2.0 pp |
| 2016 | 16.0% | ₩9.46 Billion | ₩59.16 Billion | ▲ +14.8 pp |
| 2015 | 1.2% | ₩591.75 Million | ₩49.21 Billion | ▼ -0.5 pp |
| 2014 | 1.7% | ₩787.96 Million | ₩47.34 Billion | — |